An expanded polyproline domain maintains mutant huntingtin soluble in vivo and during aging by Pigazzini, M.L. et al.
fnmol-14-721749 October 11, 2021 Time: 16:28 # 1
ORIGINAL RESEARCH




Istituto di Ricerche Farmacologiche
Mario Negri (IRCCS), Italy
Reviewed by:
Marta Valenza,












This article was submitted to
Methods and Model Organisms,
a section of the journal
Frontiers in Molecular Neuroscience
Received: 07 June 2021
Accepted: 30 August 2021
Published: 15 October 2021
Citation:
Pigazzini ML, Lawrenz M,
Margineanu A, Kaminski Schierle GS
and Kirstein J (2021) An Expanded
Polyproline Domain Maintains Mutant
Huntingtin Soluble in vivo and During
Aging.
Front. Mol. Neurosci. 14:721749.
doi: 10.3389/fnmol.2021.721749
An Expanded Polyproline Domain
Maintains Mutant Huntingtin Soluble
in vivo and During Aging
Maria Lucia Pigazzini1,2, Mandy Lawrenz1, Anca Margineanu3,
Gabriele S. Kaminski Schierle4 and Janine Kirstein1,5*
1 Department of Molecular Physiology and Cell Biology, Leibniz Research Institute for Molecular Pharmacology
in the Forschungsverbund Berlin e.V. (FMP), Berlin, Germany, 2 NeuroCure Cluster of Excellence, Charité Universitätsmedizin
Berlin, Berlin, Germany, 3 Advanced Light Microscopy, Max-Delbrück Centrum for Molecular Medicine (MDC), Berlin,
Germany, 4 Molecular Neuroscience Group, Department of Chemical Engineering and Biotechnology, University
of Cambridge, Cambridge, United Kingdom, 5 Department of Cell Biology, University of Bremen, Bremen, Germany
Huntington’s disease is a dominantly inherited neurodegenerative disorder caused by
the expansion of a CAG repeat, encoding for the amino acid glutamine (Q), present in
the first exon of the protein huntingtin. Over the threshold of Q39 HTT exon 1 (HTTEx1)
tends to misfold and aggregate into large intracellular structures, but whether these
end-stage aggregates or their on-pathway intermediates are responsible for cytotoxicity
is still debated. HTTEx1 can be separated into three domains: an N-terminal 17 amino
acid region, the polyglutamine (polyQ) expansion and a C-terminal proline rich domain
(PRD). Alongside the expanded polyQ, these flanking domains influence the aggregation
propensity of HTTEx1: with the N17 initiating and promoting aggregation, and the PRD
modulating it. In this study we focus on the first 11 amino acids of the PRD, a stretch of
pure prolines, which are an evolutionary recent addition to the expanding polyQ region.
We hypothesize that this proline region is expanding alongside the polyQ to counteract
its ability to misfold and cause toxicity, and that expanding this proline region would
be overall beneficial. We generated HTTEx1 mutants lacking both flanking domains
singularly, missing the first 11 prolines of the PRD, or with this stretch of prolines
expanded. We then followed their aggregation landscape in vitro with a battery of
biochemical assays, and in vivo in novel models of C. elegans expressing the HTTEx1
mutants pan-neuronally. Employing fluorescence lifetime imaging we could observe the
aggregation propensity of all HTTEx1 mutants during aging and correlate this with
toxicity via various phenotypic assays. We found that the presence of an expanded
proline stretch is beneficial in maintaining HTTEx1 soluble over time, regardless of
polyQ length. However, the expanded prolines were only advantageous in promoting
the survival and fitness of an organism carrying a pathogenic stretch of Q48 but
were extremely deleterious to the nematode expressing a physiological stretch of
Q23. Our results reveal the unique importance of the prolines which have and still
are evolving alongside expanding glutamines to promote the function of HTTEx1 and
avoid pathology.
Keywords: C. elegans, huntingtin (HTT), polyQ, proline, aggregation, fluorescence life time imaging, aging,
behavior - genetics - molecular
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INTRODUCTION
Huntington’s disease (HD) is a monogenic hereditary
neurodegenerative disorder caused by the expansion of a
glutamine (Q, CAG) stretch in the first exon of the protein
huntingtin (HTT) (The Huntington’s Disease Collaborative
Research Group, 1993). HD is part of a class of nine disorders
known as polyglutamine (polyQ) diseases that all share the
same pathological culprit in a polyQ expansion. In each polyQ
disorder, this unusually long Q stretch is, however, located in
different genes, expressing proteins of different functions and
generating different pathologies. In all nine disorders, CAG
repeats become pathological only above a defined threshold,
which is specific for each disease, albeit similar (Zoghbi and
Orr, 2000). For HD, the disorder is fully penetrant above the
threshold of Q ≥ 39; for intermediate alleles of 35 < Q < 39
the disease might manifest late in life, whilst for Q ≤ 35, there
is no pathology. There is also an inverse correlation between
the age of onset and severity of the disorder, with larger CAG
expansions promoting earlier onset and graver symptoms
(Wright et al., 2020). The CAG repeat, and its following CCG
triplet expansion, encoding for a polyproline (polyP) stretch,
are also highly unstable sequences (Lee et al., 2010). CAG and
CCG present with somatic variability within and throughout
brain regions, potentially contributing to symptom and onset
irregularities (Vuillaume et al., 1998; Swami et al., 2009). HD
manifests itself initially with psychiatric and cognitive symptoms,
developing into motor impairments, which lead to death within
15–20 years of onset. From a cytopathological perspective, HD
causes atrophy of the basal ganglia, a result of the extensive
loss specifically of medium spiny neurons of the striatum
(Walker, 2007).
Huntingtin is a large ubiquitous protein of 3144 amino
acids without a fully defined function. HTT is involved in
transcription, translation, synaptic signaling, vesicle transport,
mitochondrial energy production, macro-autophagy and many
other processes; its large interaction partner network also
suggests a general scaffolding role (Saudou and Humbert,
2016). Alternative splicing and several caspase-mediated
cleavage events reduce the full length HTT into progressively
smaller fragments, key of which is the ≈100 amino acid
N-terminal first exon of HTT (HTTEx1), where the polyQ
expansion is located (Graham et al., 2006; Neueder et al., 2018).
HTTEx1 is responsible for the formation of the pathology’s
hallmark amyloids structure, or inclusion bodies, found in
both the cytoplasm and nucleus of HD patient’s neurons
(Mangiarini et al., 1996; Davies et al., 1997; DiFiglia et al.,
1997). HTTEx1 has been repeatedly shown to aggregate and
form typical amyloid structures in vitro (Scherzinger et al.,
1997). Whether these insoluble aggregated structures are
at the base of neuronal toxicity is however still controversial.
Aggregation load does not consistently correlate with cytotoxicity
and aggregates themselves may have a protective role by
sequestering mutant soluble HTT (Saudou et al., 1998;
Arrasate et al., 2004). Soluble expanded mutant HTT might
exhort neurotoxic processes through both a gain of toxic
function and/or a loss of physiological function. Indeed
intermediate or oligomeric species, on pathway to fibril
formation, have also been implicated in toxicity, yet their
neurotoxic mechanism is poorly understood (Poirier et al., 2002;
Sánchez et al., 2003).
Amyloid formation is promoted by the polyQ expansion,
which folds into an antiparallel β-sheet structure held together
by the hydrogen bonding of interdigitating glutamine side
chains, in the form of a polar zipper (Perutz, 1995). Within
HTTEx1, the core polyQ domain is found encased between two
domains: an N-terminal stretch of 17 amino acids (N17) and
a C-terminal proline-rich domain (PRD), of approximately 50
amino acids (Figure 1A). The highly conserved N17 adopts an
amphipathic α-helix structure capable of interacting with lipid
membranes, chaperones and other HTT molecules; its post-
translational modifications (PTMs) modulate HTT’s function
and translocation, and enhance its aggregation potential, with
repercussions on toxicity (Arndt et al., 2015; Baias et al.,
2017). The evolutionary newer PRD adopts a left-handed
type II polyproline helix (PPII) (Darnell et al., 2009) and
was reported to delay fibril formation and assert a protective
function (Bhattacharyya et al., 2006; Dehay and Bertolotti,
2006). The PRD is composed of two stretches of pure proline
repeats (P1 and P2) separated by a proline/glutamine rich
region (Figure 1A). Proline is a unique amino acid due to
the cyclical nature of its side chain: polyP stretches impose
limited conformational flexibility and thus structural rigidity
(Williamson, 1994). Yet, proline stretches also present both
an accessible hydrophobic surface and good hydrogen bonding
sites allowing for rapid and modulated protein interactions,
with physiological relevance in transcription, cell motility
and signal transduction processes (Kay et al., 2000; Moradi
et al., 2011). Single prolines are found copiously dispersed in
intrinsically disordered regions to impose both flexibility and
function, but natural selection has also placed polyP at the
edges of aggregation-prone sequences to protect them from
self-association, ultimately acting as gate keepers (Reumers
et al., 2009; Lee et al., 2014). The PRD and the N17 flanking
domains of HTTEx1 propagate their own conformational and
physicochemical features into the polyQ stretch, influencing
its structural versatility and aggregation propensities (Caron
et al., 2013; Urbanek et al., 2020b). But while the role of the
N17 is well established, much less is understood about the
function of the PRD, and especially of its two repeated mono-
proline stretches.
In this study, we aimed to show the key and contrasting roles
of the flanking domains in modulating aggregation and toxicity
in vitro and in vivo, and specifically the involvement of the newly
evolved proline repeat immediately adjacent the polyQ (P1). We
hypothesized that in mammals the P1 domain has been evolving
and elongating in parallel to the expansion of the polyQ stretch,
with a clear purpose. The lengthening of the P1 would be able
to counteract the aggregation propensity of the expanded polyQ
to ultimately maintain HTT’s functionality in the evolution of
the nervous systems. We thus decided to empirically expand
the P1 and investigate its effect on aggregation and toxicity of
both pathogenic or physiologic HTTEx1. By generating mutants
lacking either flanking region, we first confirmed previous in vitro
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FIGURE 1 | Huntingtin exon 1: Sequence, evolution, key domains and their variations. (A) Amino acid sequence of human HTTEx1 and its domains: the first 17
amino acids (N17 – light blue), the variable polyglutamine region (polyQ – gray) and the proline rich domain (PRD – orange), which includes two stretches of pure
polyproline (P1 and P2). (B) Alignment of human huntingtin HTTEx1 and of selected species. Amino acids relevant for this study are highlighted: glutamines (Q) in
gray, prolines (P) and the P1 region, shaded and contoured, in orange. (C) Schematics of the HTTEx1 mutants generated for this study: HTTQn* is the non-variated
HTTEx1, in HTTQn-1P the proline rich domain (PRD) was deleted; in HTTQn-P+ the first proline stretch (P1) of the PRD was expanded from 11 to 22 prolines; in
HTTQn-1P1 the whole first proline stretch (P1) has been deleted; and in HTTQn-1N17 the first 17 amino acids have been deleted. Domains are color coded
throughout the study: N17 in light blue, polyQ in gray and PRD in orange. Regarding the polyQ, all mutants contain either a non-expanded and physiological Q23 or
pathogenic Q48 stretch. (D) Graphical representation of the fusion constructs used in this work: for the in vitro investigations, HTT constructs are tagged
N-terminally to a removable GST-tag, and C-terminally to either CyPet or YPet fluorophore, or nothing. For the in vivo analysis, HTTEx1 is either fully untagged, or
fused N-terminally with a nematode adapted mScarlet fluorophore.
findings of the effects of the N17 and the PRD domains. When
doubling the size of the P1 stretch, we uncovered in vitro an
increase in aggregation propensity, promoted by the PRD. This
heightened aggregation propensity was, however, not replicated
in vivo and instead HTTEx1 mutants with an expanded polyP
remained soluble over time. To understand the contribution of
the flanking domains in a physiological and cellular context,
we generated the first Caenorhabditis elegans (C. elegans) strains
expressing pan-neuronally the HTTEx1, complete or with its
mutated flanking domains. Employing fluorescence lifetime
imaging (FLIM) we were able to distinguish the formation of
soluble vs oligomeric vs aggregated species in vivo and during
aging, and correlate these to toxicity at an organismal level. Our
results confirmed the deleterious effects imposed by a missing
PRD, while highlighting the benefits of possessing an expanded
polyP domain in the presence of an expanded polyQ. To our
surprise, a long polyP stretch flanking a physiological polyQ
sequence was instead highly deleterious to the nematode’s fitness.
We conclude that in their evolutionary expansion, HTTEx1’s
glutamine and proline tracts are poised to find a functional
balance, while avoiding the risk of pathology.
MATERIALS AND METHODS
Gene Alignment and Species
Comparison
FASTA sequences were obtained by searching the NCBI Protein
Database after performing a BLAST search against the human
HTTEx1 sequence. Alignments and coloring of selected species
sequences were generated manually in Jalview (v. 2.11.1.0)
(Waterhouse et al., 2009). Sequence accession codes are as follow:
Homo sapiens (NP_002102.4), Sus scrofa (NP_999129.1), Bos
taurus (XP_002688476.2), Felis catus (XP_023109234.1), Pan
troglodytes (XP_016806693.2), Pongo abelii (XP_024101641.1),
Pan pansiscus (XP_003813027.3), Ovis aries (NP_001136110.1),
Frontiers in Molecular Neuroscience | www.frontiersin.org 3 October 2021 | Volume 14 | Article 721749
fnmol-14-721749 October 11, 2021 Time: 16:28 # 4
Pigazzini et al. Expanded PRD Maintains HTT Soluble
Canis lupus familiaris (XP_038517621.1), Rattus norvegicus
(NP_077333.2), Mus musculus (NP_034544.1), Gallus gallus
(XP_420822.3), Danio rerio (NP_571093.1), Xenopus tropicalis
(XP_031751173.1), and Drosophila melanogaster (NP_651629.1).
Generation, Expression and Purification
of in vitro Non-tagged HTTEx1 Mutant
Constructs
HTTEx1 constructs containing the flanking region variations
were synthetized in pUC57 plasmids. 1P, P+ and 1N17
constructs were synthetized by BioCat GmbH (Heidelberg), while
non-variated HTTEx1 and 1P1 mutant were synthetized by
GenScript United States Inc. (Piscataway, NJ, United States).
In all plasmids, the HTTEx1 sequence was preceded by the
restriction enzyme sites SacII, PstI and BamHI and succeeded
by the sites XhoI, NotI and MluI, in this order. All sequences
ended with a stop codon and were synthetized with a stretch of
either Q23 or Q48. HTTEx1 mutants were cloned into a pGEX-
6P-1 backbone between BamHI and XhoI, and transformed
into BL21-CodonPlus (DE3)-RIPL competent cells (Agilent,
#230280). Expression of a fully-grown culture was induced by the
addition of 1 mM IPTG and left at 20◦C overnight, shaking at
200 rpm. Cells were harvested and resuspended in lysis buffer
(50 mM NaH2PO4, 5 mM Tris, 150 mM NaCl, 1 mM EDTA,
pH 8.0) supplemented with 2 mM phenylmethylsulphonyl
fluoride, DNase and cOmpleteTM Protease Inhibitor Cocktail
tablets (Roche). Cells were lysed by shredding using the
LM10 microfluidizer set at 18.000 psi, for 5 consecutive cycles
(Microfluidics International Corporation). After lysis, TritonX-
100 was left to dissolve to a final concentration of 1% (v/v) and
the lysate was centrifuged at 30.000× g for 40 min at 4◦C (Sorvall
LYNX 4000, Thermo Scientific). The resulting supernatant was
mixed with pre-washed glutathione sepharose 4B beads (GE
Healthcare) and incubated at 4◦C for 90 min rolling. The lysate
was then applied to a polypropylene column (Qiagen, #34964)
and washed twice with wash buffer (50 mM NaH2PO4, 5 mM
Tris, 150 mM NaCl, 1 mM EDTA, 0.1% (v/v) Triton-X-100, pH
8.0). After washing, beads were incubated for 30 min at RT with
elution buffer (50 mM NaH2PO4, 5 mM Tris, 150 mM NaCl,
1 mM EDTA, 20 mM reduced glutathione, pH 8.6). The resulting
eluate was dialyzed against storage buffer (50 mM Tris, 150 mM
NaCl, 1 mM EDTA, 5% (v/v) glycerol, pH 7.4) for 16 hours at
4◦C. Proteins were assessed for purity via SDS-PAGE analysis and
stored at−80◦C.
Cloning and Purification of
CyPet/YPet-Tagged HTTEx1 Mutant
Constructs
HTTEx1-CyPet/YPet mutants were created by modifying the
plasmid sequence of the GST-HTTEx1Q48/23 -CyPet and GST-
HTTEx1Q48/23 -YPet constructs (Scior et al., 2018). To remove
the stop codon and add appropriate restriction sites, plasmids
of HTTEx1-P+ and 1P1 mutants were amplified by PCR
using the forward primer: cgccgcggatccatggcgaccctggaaaagctg; and
reverse primer: ccgccgctcgagtggtcggtgcagcggctcctc. 1P and 1N17
mutants without an AUG codon at the C-terminus of HTTEx1
sequence were synthetized by BioCat GmbH (Heidelberg). PCR
or plasmid-derived mutant DNA were sub-cloned into the
GST-CyPet or GST-YPet backbone, between BamHI and XhoI.
Expression and purification of HTTEx1-CyPet/YPet constructs
were performed as described above for non-tagged constructs.
In vitro Aggregation Assays
Prior to all in vitro experiments, GST-HTTEx1-X proteins were
thawed on ice, ultra-centrifuged at 154.000xg for 45 min at
4◦C (Rotor TLA55, Beckman Coulter) and their concentration
determined via Bradford assay. Unless otherwise stated,
aggregation was performed at 30◦C and 450 rpm shaking in
aggregation buffer (30 mM Tris–HCl, 150 mM NaCl, 1 mM
EDTA, 1 mM DTT, pH 7.4). Proteins were subjected to Tris-
Glycine 10% SDS–PAGE and stained with InstantBlue protein
stain (Sigma) or employed for Western blotting.
Atomic Force Microscopy Sample
Preparation and Imaging
3 µM HTTEx1 and 14 U PreScission protease (PP) (GE
Healthcare) were incubated in a volume of 20 µl for either 2,
4 or 24 h. The whole sample volume for each time point was
spotted onto a freshly cleaved mica surface and left to dry at
RT for 10 min. Samples were washed with 40 µl ddH2O four
times and left to dry covered for 48 hours at RT. Imaging was
performed using the digital multimode NanoWizard II (JPK)
atomic force scanning microscope operating in intermittent-
contact air tapping mode and image analysis was performed with
JPK Software analysis package (Bruker Nano GmbH).
Semi-Denaturing Detergent Agarose Gel
Electrophoresis
Semi-Denaturing Detergent Agarose Gel Electrophoresis (SDD-
AGE) gels for detection of amyloids were performed based on
previously described protocols (Halfmann and Lindquist, 2008),
with an HTTEx1 starting concentration of 3 µM. At 4 and
24 h after addition of PP, 4x Laemmli buffer (LB) without
SDS (0.125 M Tris–HCl, 20% glycerol, 10% 2-mercaptoethanol,
0.004% bromophenol blue) was added to the aggregated reaction
and incubated at RT for 7 min. Samples were immediately
loaded on a 1.8% agarose gel in 1xTAE containing 0.1% SDS
and subjected to 22V for 20 h on ice in a cold room in 1xTAE
buffer supplemented with 0.1% SDS. TEA agarose gels were
subsequently laid onto a same-sized nitrocellulose membrane
with 0.2 µm pore size (GE Healthcare, #10600004) and placed
onto a 25-piece stack of thick Whatman blotting paper (GB002).
Paper, gel and nitrocellulose stack were covered with a wet wick
reaching into two PBS reservoirs, and a heavy weight was applied
on top of the ensemble. Proteins were left to transfer via capillary
action for 24 h at RT. The membrane was then blocked in 5%
skim milk in TBS-T and incubated overnight at 4◦C with primary
antibodies in 3% skim milk in TBS-T. Membranes were incubated
with the primary anti-HTTEx1 antibodies EPR5526 (1:2000,
Abcam) and MW8 (1:2000; DSHB) and subsequently probed
with secondary antibodies conjugated to horseradish peroxidase
(HRP) against rabbit or mouse (1:10,000; #31460 and #31444
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respectively, Thermo Fisher). Signals were developed with Pierce
ECL Western Blotting Substrate (#32209, Thermo Fisher) and
imaged on a Lumi-Imager F1 system employing LumiAnalyst
software (Boehringer Mannheim GmbH).
Filter Retardation Assay
Filter retardation assay (FRA) was performed as previously
described (Ast et al., 2018b), utilizing a final protein
concentration of 1.5 µM. The addition of PP started the
aggregation process. At the indicated time points at 0, 4, 8 and
24 h after addition of PP, an aliquot was taken from each sample
and flash frozen in liquid nitrogen. Before blotting, samples were
mixed 1:1 v/v with a stop solution (4% SDS, 100 mM DTT).
In a dot blot apparatus attached to a pump, whole samples
were loaded on and filtered simultaneously through a cellulose
acetate membrane with 0.2 µm pores (OE66, GE Healthcare,
#10404180) pre-soaked in TBS buffer containing 1% SDS. All
blot wells were washed twice with TBS plus 0.1% SDS and
membranes were then blocked in 5% skim milk in TBS-T. Fibrils
retained on the membrane were detected by probing with both
anti-HTTEx1 primary antibodies EPR5526 (1:1000; Abcam) and
MW8 (1:2000; DSHB). Anti-rabbit HRP secondary antibody
(1:10,000; #31460, Thermo Fisher) was used to probe HTTEx1
EPR5526 and IRDye680 anti-mouse (1:10.000; #926-68070 LI-
COR Biosciences) was used for detection of MW8. HRP signals
were developed with Pierce ECL Western Blotting Substrate
(#32209, Thermo Fisher) and imaged using the OdysseyFC
imaging system (LI-COR Biosciences).
Sodium Dodecyl Sulfate Stability Assay
1 µM HTTEx1 was left to aggregate for 24 h after addition
of PP. At that point, either 0,1% SDS or 2% SDS (v/v) was
added to each sample and tubes were heated at 60◦C for 10 min.
Samples were then spun at 154.000 × g for 20 min at 4◦C (Rotor
TLA55, Beckman Coulter). Subsequently, 80% of supernatant
was carefully transferred to low-binding tubes containing 4xLB
without SDS, gently mixed, and finally boiled for 5 min at
100◦C. Samples were subjected to 10% SDS–PAGE gels in Tris-
Glycine buffer and transferred on a nitrocellulose membrane
via semi-dry blotting (Trans-Blot Turbo System, BioRad).
Western blotting procedures and development were performed
as described above and membranes were probed with the
primary HTTEx1 antibody 5TF1-1C2 (1:5000, Merck) and HRP-
conjugated secondary anti-mouse antibody (1:10,000, #31444,
Thermo Fisher). Quantification of the intensity measurements
of the blots were performed using the software Fiji/ImageJ
(Schindelin et al., 2012).
Förster Resonance Energy Transfer
Assay
Förster resonance energy transfer (FRET) assay was performed
as previously described (Ast et al., 2018a; Scior et al., 2018).
Purified CyPet-YPet pairs of each HTTEx1 mutant were diluted
in FRET aggregation buffer (30 mM HEPES-KOH, 150 mM
KCl, 5 mM MgCl2, 1 mM DTT, pH 7.4) in equimolar
ratios to yield a final concentration of 3 µM. For spiking
experiments, equimolar ratio of tagged vs untagged mutants
was used, still maintaining a final concentration of 3 µM. For
experiments with Q481P titrations, the ratio of untagged 1P was
gradually increased while the CyPet-YPet decreased, but always
maintaining a final concentration of 3 µM. For experiments
including HTTEx1Q23 mutants, concentrations were increased
to a total of 40 µM to accelerate aggregation. 5 mM ATP,
3 mM phosphoenolpyruvate and pyruvate kinase were added
to the reaction, and a final addition of 14 U of PP initiated
the aggregation process. Reactions were split into triplicates in
a black 384-well plate. Using a Tecan F200Pro plate reader
(Tecan Trading AG), fluorescence signals were recorded every
30 min for constructs containing Q48, and every hour for
constructs containing Q23. Experiments were performed for a
minimum of 15 and a maximum of 660 h. Fluorescence of
the donor CyPet constructs (DD) was measured at 430/485nm
emission/excitation; the YPet acceptor (AA) was measured at
485/530nm emission/excitation; and the FRET channel (DA) was
collected at 430/530nm emission/excitation. For data processing,
the background fluorescence signal of each channel was removed
from all respective values. The FRET signals were corrected for
donor bleed-through (cD) and acceptor cross excitation (cA) by
using donor- or acceptor-only values. This was performed for
each mutant independently. A final sensitized FRET emission
was normalized to the acceptor. The apparent FRET efficiency
(EApp), expressed in percentage values, was therefore calculated
as: E = (DA-cD∗DD-cA∗AA)/AA (Jiang and Sorkin, 2002). All
EApp values were expressed in percentage, set to zero and
normalized to HTTEx1Q48-CyPet/YPet signals.
Cloning of Mutant HTTEx1 Constructs
for Nematode Expression
Constructs for generation of the HTTEx1 C. elegans strains
for fluorescence lifetime imaging were created by modifying
the neuronal wrmScarlet::Aβ1−42 plasmid (Gallrein et al.,
2021). Gibson assembly (E2611L, New England Biolabs) was
used to remove the Aβ peptide and to create a backbone
including new restriction enzyme sites for addition of HTTEx1.
A linear backbone comprising the neuronal promoter, resistance
gene, origin of replication and the unc-54-3′UTR regulatory
regions was generated using the following forward and reverse
primers: ctgcagtgcattggataagaatgcggccgcTAGCTCGAGAT-
ACCCAGATCATATGAAACGG and acgcgtcgcgtcctccccgcgg
CCCGGTCGTcgtcgtcgtcgatgccgtc. The sites NotI and PstI,
separated by the base pairs tgcattggataagaat, were introduced
at the 5′-end of this amplicon, and the SacII and MluI sites,
interspaced by the base pairs ggaggacgc, were added to the
3′-end of the plasmid. A smaller PCR product including the
sequences for the hsp3IRES region and the mScarlet fluorophore




resulting plasmid was used as starting point to create all HTTEx1
nematode constructs. This plasmid was further employed,
unchanged, to create a control strain that would express only the
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mScarlet fluorescent protein. Introduction of the two moieties
of HTTEx1 was performed in two steps. First, HTTEx1 was
introduced downstream of the IRES-mScarlet sequence between
NotI and PstI. Then, a second HTTEx1 sequence, identical to
the first, was introduced downstream of the rgef-1 promoter and
before the IRES-mScarlet sequence, between SacII and MluI. All
cloning was confirmed via Sanger sequencing (LCG Genomics)
to ensure constructs included two correct HTTEx1 moieties. For
detailed genotype of each C. elegans strain generated please refer
to Supplementary Table 1.
Generation and Maintenance of HTTEx1
C. elegans Strains
All transgenic strains were generated by microinjection following
previously established protocols (Mello et al., 1991). For each
HTTEx1 construct, 5–20 ng/µl of plasmid DNA plus filler DNA
to 200 ng/µl (DNA Ladder, #SM0311, Thermo Fisher) were
injected into 20 wild type N2 nematodes, progeny was scored
for red fluorescence and positive nematodes singled out. Extra-
chromosomal arrays of HTTEx1 nematodes were integrated via
UV irradiation, following the previously described procedure,
and 100% transmitting positive lines were backcrossed four times
against N2 wild type. For imaging experiment, non-integrated
HTTEx1 nematodes lines were employed, while phenotypic
assays were conducted with integrated and backcrossed lines. All
C. elegans strains were maintained on nematode growth media
(NGM) plates seeded with E.coli OP50 at 20◦C, according to
standard practice (Stiernagle, 2006).
Confocal Imaging of Live C. elegans
HTTEx1 Models
Nematodes were mounted on 3% agarose pads precast on
microscopy slides and were anesthetized with 2 mM levamisole
(#A4341, AppliChem GmbH). Imaging of the mScarlet (561/630
ex/em) was performed on an inverted Zeiss LSM710 ConfoCor3
and using Zeiss C-Apochromat 10x/0.3W or PLAN-Apochromat
63x/1.40 Oil DIC M27 objectives (Carl Zeiss AG). Image
processing and analysis was performed with Fiji/ImageJ.
Time Correlated Single Photon Counting
Fluorescent Lifetime Imaging of HTTEx1
C. elegans Strains and Image Analysis
Fluorescence lifetime imaging of HTTEx1 C. elegans was
performed as described in detail previously (Pigazzini et al.,
2020). Briefly, nematodes were age synchronized via egg laying
and grown on NGM plates seeded with OP50 at 20◦C, for either
4 or 10 days. Nematodes were mounted on 3% agarose pads
precast onto microscopy slides and were anesthetized with either
2 mM levamisole for day 4 nematodes, or 0.5 mM levamisole for
day 10 nematodes. TCSPC-FLIM was performed on an inverted
Zeiss AxioObserver.Z1 (Carl Zeiss AG) confocal microscope
connected to a B&H DCS-120 SPC-150 TCSPC acquisition
hardware and B&H SPC830-SPC Image software (Becker &
Hickl GmbH). Images were acquired using a Zeiss ApoE
63x/1.20 Oil objective and with 1.5x magnification. mScarlet was
excited with a 50 MHz 60 ps pulse width 561 nm laser. The
emission was collected through a combination of a 575 long
pass and a 628/40nm bandpass filter. Photons were collected for
120 s per nematode. Intensity decay fitting was performed with
FLIMfit software (v 5.1.1) (Warren et al., 2013) using reference
deconvolution (measured with an erythrosine B solution in
water). Although the decays showed a multiexponential profile,
to simplify the data interpretation we performed an image-
wise fit using a single exponential model that accounts for the
average lifetime.
Lifespan Assay
C. elegans were age synchronized by egg laying for 4 hours at 20◦C
and kept at 20◦C throughout the whole experiment. On day 3,
120-180 L4 nematodes were divided onto 5 NGM plates seeded
with OP50. C. elegans were counted daily and scored as alive,
dead, or censored. Nematodes were passaged daily to fresh plates
until day 10, after which they were only passaged if necessary.
Three biological repeats for each strain were performed. The
Kaplan Mayer method was used to calculate and compare the
survival distribution of two or more groups. A log-rank (Mantel-
Cox) test was used to estimate significance. Lifespan results were
calculated using the online OASIS 2 tool (Han et al., 2016); results
from this analysis are available in Supplementary Table 3.
Progeny Assay
Nematodes were age synchronized by egg laying for 4 h at 20◦C
and kept at 20◦C throughout the whole experiment. On day
2 after hatching, 20 nematodes were placed individually on an
NGM plate seeded with OP50. Once egg laying began, nematodes
were passaged daily to a fresh plate, and eggs were left to hatch
at RT for 24 hours before being counted. Progeny was counted
for five days. Three independent biological repeats for each strain
were performed and the average± SD of all triplicates combined
was used for statistical analysis.
Chemotaxis Assay
C. elegans were age matched via alkaline hypochlorite solution
treatment (Porta-de-la-Riva et al., 2012). Chemotaxis assay
was performed as described previously (Margie et al., 2013).
Briefly, on day 4 after synchronization, nematodes were collected
from synchronized NGM plates and washed 5x times with M9
solution to fully remove OP50. Nematodes were left to starve
in M9 at 20◦C for 30 minutes before commencing the assay.
Nematode pellet was then separated onto plates pre-prepared
with either an attractant (1% benzaldehyde, v/v), a repellent (50
% benzaldehyde, v/v) or a control (50% EtOH, v/v) solution. All
test solutions were dissolved 1:1 in 500 nM sodium azide. 2 µl
of chemotactic substance or control were placed on opposing
quadrants of a single plate divided into four regions. 50-150
nematodes were pipetted at the center of a plate and left to
crawl towards or away from the chemotactic test substance. The
assay was performed at 20◦C for 2 h in the dark, after which
plates were placed at 4◦C for a further 2 h to stop nematodes
from moving. Nematodes in each quadrant were counted and
a chemotaxis index (CI) was calculated as # of nematode in
test quadrants minus # of nematodes in control quadrants,
divided by total number of nematodes that left the center. Three
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independent biological repeats for each strain were performed
and the average ± SD of each CI was then calculated and used
for statistical analysis.
Thrashing Assay
Caenorhabditis elegans were age synchronized by egg laying for
4 h at 20◦C and kept at 20◦C throughout the whole experiment.
On either day 4 or 10, a single nematode was picked into
200 µl of M9 liquid and left to acclimatize for 30 s, before
manually counting the number of thrashes performed in the
subsequent 30 s. A single thrash is defined as a complete
movement from minimum to maximum amplitude, and back.
Cohorts of at least 10 nematodes each were analyzed in three
independent biological replicates, and significance was calculated
from these measurements.
Statistical Analysis of FLIM
Measurements and Phenotypic Assays
All statistical analysis was performed using Prism8 (GraphPad
Software). Unless otherwise stated, to determine statistical
significance for lifetime changes and most phenotypical assays,
a one-way ANOVA followed by Tukey’s post hoc analysis
method was employed.
RESULTS
Proline Residues Are Expanding
Alongside Glutamines
Huntingtin is well conserved throughout species (Gissi et al.,
2006; Tartari et al., 2008). Prior investigations have revealed that
glutamine residues are positionally conserved in deuterostomes
and their numbers are increasing in size during evolution.
First appearance of the HTT gene dates back millennia and
orthology studies have identified a primordial version of HTT
in amoeba and the first appearance of a single glutamine amino
acid in the sea urchin. Significant lengthening of the glutamine
stretch appears in vertebrates and correlates with increased
sophistication of the nervous system (Tartari et al., 2008). Indeed,
HTT has a clear function in brain development and is key in
the early stages of gastrulation (Barnat et al., 2020). Removal
of HTTEx1 is embryonically lethal, and conversely, longer
glutamine stretches were reported to correlate with increase
in gray matter volume (Nasir et al., 1995; Beste et al., 2008;
Zuccato and Cattaneo, 2016; Conforti et al., 2018). While the
importance of the polyQ sequence in development, growth and
neuronal processing, as well as in aggregation and toxicity,
is widely studied and accepted, the impact of the flanking
regions has not been as extensively investigated. Similarly
to prior investigations, we aligned the amino acid sequences
of HTTEx1 homologues of selected species of vertebrates,
according to their expanding polyQ domain (Figure 1B).
The N17 is extremely conserved throughout these species, as
is the final part of the PRD domain (PGPAVAEEPLHRP),
comprising the second unusually long polyP stretch (P2).
Importantly, the polyP domain immediately adjacent to the
polyQ (P1), a sudden addition exclusively in mammals, is also
highly conserved (Brandi and Polticelli, 2021). Furthermore,
from this alignment it is noticeable that the P1 domain is
expanding, similarly, and alongside the polyQ domain. Primates
such as the orangutan (Pongo abelii), evolutionary closer to
humans, present an uninterrupted stretch of prolines, while
other mammals present a proline stretch that is interrupted
by the presence of other amino acids such as glutamines
or leucines (Barnes et al., 1994; Schmitt et al., 1995; Tartari
et al., 2008). The importance and function of the elongated
proline stretch, either interrupted or not, is however not
fully characterized.
Our investigation aimed to understand the importance of
the expanding P1 region, and in general of the PRD. We
generated HTTEx1 mutants containing either physiological
Q23 or pathological Q48, and variating flanking domains: we
removed the whole PRD domain (1P), we arbitrarily doubled
the polyproline domain from a typical 11P to a 22P (P+) stretch,
we deleted the first polyP stretch only (1P1) and finally, we
eliminated the first 17 amino acids (1N17) (Figure 1C). To
investigate the impact of these HTTEx1 mutants in vitro we
employed purified recombinant proteins, generated without or
tagged with fluorescent probes. Similarly, to study the same
mutants in vivo with regards to their aggregation propensity
and toxicity, we leveraged the advantages of fluorescent fusion
constructs expressed in the C. elegans model system (Figure 1D).
Huntingtin Exon 1 Mutants Lacking a
PRD Domain or Harboring an Expanded
Proline Stretch Exhibit High Aggregation
Propensities
The aggregation kinetics of HTTEx1 have been extensively
investigated (Hoffner and Djian, 2015), but the contribution of
the P1 region to the aggregation process is poorly characterized.
We thus first set out to dissect the impact on aggregation
of the P1, and generally the PRD, and hypothesized that an
expanded polyP (P+) mutant could delay aggregation kinetics
in vitro, while removing the P1 (1P1) would favor it. HTTEx1
aggregation speed correlates with increased polyQ length and
fragment concentration (Yushchenko et al., 2018), following a
nucleation/polymerization growth mechanism (Jayaraman et al.,
2012). The N17 is responsible for initiation and accentuation
of HTTEx1 oligomerization, through self-anchoring and PTMs
(Gu et al., 2009; Thakur et al., 2009; Sivanandam et al.,
2011). Conversely, the PRD has been shown to diminish
the aggregation propensity in vitro, ex vivo and in yeast,
slowing the formation of aggregates (Dehay and Bertolotti,
2006; Darnell et al., 2009; Shen et al., 2016). Our initial results
also confirmed these profound impacts of the N17 and PRD
flanking domains on the morphology and aggregation kinetics
of HTTEx1: the contribution of the P1 itself however was more
complex to discern.
We expressed HTTEx1 mutants as recombinant proteins
N-terminally attached to a glutathione S-transferase (GST) tag
(Supplementary Figure 1A). Excision of the GST-tag by the
action of the PreScission protease (PP) liberates the HTTEx1
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fragment from its fusion constructs and permits the start
of aggregation (Figure 2A). We first confirmed that flanking
domains had different, and opposing, impacts on the morphology
of HTTEx1 mutants all containing a Q48 pathologic stretch.
We employed atomic force microscopy (AFM) to visualize and
compare at nanometer scale the aggregates formed by HTTEx1
mutants over time (Figure 2B). Previous imaging studies had
already illustrated the capability of HTTEx1 to form visible
fibrillar structures (Scior et al., 2018). After allowing mutants
to aggregate spontaneously for 2, 4 or 24 h, we immediately
noticed that at 2 h of aggregation, the 1P mutant created large
and intricate patterns of long and dispersed fibrillar fragments.
Similar shapes were found at 4 h of aggregation, while at 24 h the
size of the aggregates had overcome the field of view, stretching
for > 10 µm in size (Figure 2B – second column). These fibrillar
structures represent the aggressive aggregation propensity of the
1P mutant, which is devoid of the protective or aggregation-
delaying PRD domain. Conversely, the 1N17 mutant, which
lacks the aggregation initiating N17 domain, promoted the
formation of only few fibrils, even over 24 h (Figure 2B – fifth
column). Somewhat unexpectedly, P+ constructs also showed a
propensity to form aggregates already at 2 h of aggregation, with
large ensembles of fibrils at 4 h, which increasingly condensed
and expanded at 24 h (Figure 2B – third column). These
observations contrast with our expectation of an inhibitory role
for the polyP on HTTEx1 aggregation, and instead the P+
mutant favored and accelerated aggregation compared to both
the non-variated HTTEx1 and the 1P1 mutant. In fact, while
non-variated Q48∗ already formed aggregates at 4 h and larger
structures at 24 h (Figure 2B – first column), the 1P1 mutant
exhibited aggregated bundles only at 24 h, highlighting the
inability of the P1 to fully suppress the aggregation propensity
(Figure 2B – fourth column).
Because of the counterintuitive outcomes of the AFM images
for the P+ and 1P1 mutants, we wanted to corroborate the
morphological results with additional biochemical assays. To
gain better insight of the different species of oligomers/aggregates
formed by each mutant over time, we performed a semi-
denaturing detergent agarose gel (SDD-AGE) followed by
Western blotting (Figure 2C). Already at 4 h, non-variated
Q48∗, 1P and P+ mutants presented oligomeric species,
that migrated at a high molecular weight of approximately
300 kDa, representing very different structures from the single
globular moiety detectable at approximately 55 kDa (Figure 2C,
Supplementary Figure 1A). At 24 h after aggregation initiation
an intense signal was present for the 1P mutant, as aggregated
material that cannot migrate through the matrix of the agarose
is retained in the pockets of the gel. Similar trapped material
appeared for non-variated Q48∗ and for the 1P1 mutant,
suggesting that these aggerates are of a large and insoluble
nature, confirming the AFM experiments (Figure 2B). For the
P+ mutant, oligomeric species appeared in the middle of the gel
lanes at both 4 and, more intensely, 24 h, possibly illustrating the
presence of a more heterogenous population of aggregates; while
again for the 1N17 a very faint signal appeared only at 24 h,
confirming its reluctance to aggregate. To further investigate the
kinetics of aggregation of the HTTEx1 mutants we performed
a filter retardation assay (FRA) (Ast et al., 2018b; Figure 2D).
Samples from each aggregated mutant were analyzed at 0, 4,
8, and 24 h after aggregation initiation. At these time points,
soluble material that was not trapped on the membrane passed
through its pores, while aggregated moieties were retained on
its surface. The FRA demonstrated that, once again, the 1P
mutant exhibited the fastest aggregation kinetics, generating a
strong signal already 4 h after aggregation initiation. The P+
mutant similarly exhibited aggregated material early, while the
non-variated Q48∗ and the 1P1 aggregates appeared at around
8 h. Signals from 1N17 mutant were only detected after 24 h of
aggregation. Overall, the results of the FRA were in agreement
with our data obtained from the AFM and SDD-AGE assays
(Figures 2B,C). Both FRA and SDD-AGE are a qualitative
addition to the AFM results, which provided only a snapshot of
single timed events in the aggregation pathway. Quantification
was hindered by the unavailability of a single antibody to detect
all mutants in both assays. As no single antibody tested (EPR5526,
3B5H10, 5TF1-1C2, EM48, MW4, MW8, MW7) was able to
recognize all HTTEx1 mutants simultaneously, a combination
of two antibodies was therefore employed here: such a strategy
prevented proper quantification of the signals (Figures 2C,D,
Supplementary Figure 1C).
Finally, to assess the insolubility of aggregates formed by
these mutants, we designed an assay to investigate their stability
and resistance to sodium dodecyl sulfate (SDS) (Figures 2E,F,
Supplementary Figure 1D). Addition of SDS to protein reactions
or cell lysates is widely acknowledged as a method to promote
solubilization, and thus allows to distinguish and separate soluble
from truly aggregated, SDS-insoluble, species (Juenemann et al.,
2015). HTTEx1 mutants were left to aggregate for 24 h and
then treated with 2% SDS. Soluble versus insoluble fractions
were separated by ultracentrifugation and the abundance of the
soluble fraction, a readout of the fragility of the aggregates,
was quantified by Western blotting (Figure 2E). Despite a high
variability between repeats, the analysis revealed a clear trend.
The 1P mutant formed highly SDS-insoluble aggregates and no
soluble fraction was detected, highlighting that all monomeric
moieties are involved in the formation of these 1P aggregates.
Conversely, and regardless of its concentration, SDS was able to
resolubilize larger species of all other mutants, similarly to the
non-variated Q48∗ control.
From these in vitro results it emerged that the complete
removal of the PRD exacerbated the aggregation capacity
of HTTEx1. 1P mutants rapidly form large and SDS-
insoluble aggregates, incorporating quickly all available soluble
protein. Expansion of the P1 did not alleviate aggregation, as
hypothesized, and instead P+ mutants exhibited an increased
aggregation propensity. However, the oligomeric species
generated by the expanded P+ mutant, as illustrated by SDD-
AGE and AFM assays, might be the product of long proline
stretches that self-associate specifically in vitro and in the absence
of other interactors. This self-binding might be transitory and
thus easier to resolubilize upon treatment with SDS. Also,
unexpectedly, the 1P1 mutant failed to enhance the aggregation
propensities of HTTEx1, and rather behaved like the non-
variated Q48∗ throughout most biochemical assays. The 1N17
Frontiers in Molecular Neuroscience | www.frontiersin.org 8 October 2021 | Volume 14 | Article 721749
fnmol-14-721749 October 11, 2021 Time: 16:28 # 9
Pigazzini et al. Expanded PRD Maintains HTT Soluble
FIGURE 2 | In vitro characterization of HTTEx1 mutant reveals a high aggregation potential for constructs without the PRD and with expanded prolines.
(A) Schematic of the in vitro experimental set-up employed for all assays pictured herein. HTTEx1 mutants are purified fused to a GST-tag. Upon addition of the
PreScission protease (PP), the GST-tag is cleaved and HTTEx1 moieties begin their aggregation process, transitioning from a soluble to an oligomeric and into a
higher order aggregated structure. (B) AFM images of spontaneous HTTEx1 mutant aggregates and their unique morphology, at 2, 4 or 24 h after addition of PP.
White to black color gradient represents 0 to 15 nm height. Scale bar for top three rows is 500 nm. Fourth row represents the wider field of view of scans in row
three obtained at 24 h, scale bar is 2 µm. Dashed boxes represent the region of interest selected and magnified in the third row. (C) SDD-AGE of HTTEx1 mutants at
4 and 24 h after addition of PP. Lanes represent the different species of high molecular weight structures generated by each mutant: fibrillar species are at the top,
trapped in the gel pockets, smears represent high molecular weight oligomeric/protofibrillar species, and lower signals are low molecular weight oligomers.
Immunoblot stained with both the N17 specific EPR5526 and proline-binding MW8 antibodies. Gel shown here is representative of at least three independent
replicates. (D) FRA showing the different time-dependent aggregation kinetics of HTT mutants. Samples were taken at 0, 4, 8 and 24 h after addition of PP and
loaded in triplicates. Immunoblot was performed simultaneously with both the N17 specific EPR5526 antibody (left panel) or the MW8 proline region specific
antibody (middle panel); right panel shows the merge of both. Blots are representative of at least three independent repeats. (E) Descriptive graphical abstract and
Western blot analysis of the SDS stability assay. Blots represent the amount of soluble HTTEx1 present upon treatment with 2% SDS after 24 h of aggregation.
Immunoblot stained for the polyQ-specific 5TF1-1C2 antibody. Bands utilized for quantification are boxed; lower bands represent truncated species and were not
quantified. Shown here is one of three independent repeats. (F) Quantification of three independent SDS-SA, as per example shown in (E). Values are normalized to
Q48* and show mean ± SD; statistical significance was calculated using an ordinary one-way ANOVA followed by Tukey post hoc test and assuming 95%
confidence interval (∗∗∗ = p < 0.0002; ∗∗∗∗ = p < 0.0001).
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mutant instead performed exactly as expected, promoting little
aggregation over long time periods and thus highlighting the
importance of the N17 domain in initiating aggregation.
Deletion or Expansion of PRD Domains
Alters Aggregation Kinetics Also for
Short Q Variants
Results from the biochemical assays above generally confirmed
the role described previously for the flanking domains (Crick
et al., 2013; Phan and Schmit, 2020). However, some questions
arose when considering the effects of the P1 which we
hypothesized could respectively reduce (P+) and increase (1P1)
the aggregation potential of HTTEx1. We therefore proceeded
to further quantify the aggregation kinetics by continuously
monitoring the aggregation landscape of HTTEx1 via a FRET
based assay. We now assessed the effects of the flanking regions
by exploring their behavior also in the presence of a physiological
Q23. We generated recombinant GST-tagged HTTEx1 mutants
tagged N-terminally to either a CyPet or YPet fluorescent protein,
which together constitute a strong FRET pair (Supplementary
Figure 1B). When tagged to an aggregation prone protein, an
increase of the FRET signal over time becomes a readout of
the aggregation kinetics, illustrated in the form of a sigmoidal
curve (Figure 3A; Ast et al., 2018a; Scior et al., 2018). When
comparing all mutants tagged with CyPet/YPet we were able
to replicate the results from our previous biochemical assays
(Figure 2). Already 2 h after cleavage of the GST-tag, the P+
mutant (orange line) commenced a fast aggregation process,
represented by the steep slope, and reached a plateau within
5 h. In comparison, the non-variated Q48 (gray line), acting
as a control, started its aggregation 4 h later. The 1P1 mutant
(purple line) closely followed the control, while the 1N17
(green line) exhibited the slowest aggregation initiation and
fibrillization, reaching a plateau only over a very extended time
lapse (Figure 3B). The slopes of these three mutants, Q48, 1P1
and 1N17, were also of lesser inclination indicative of milder
aggregation kinetics. Unexpectedly, the 1P mutant (blue line),
which all previous biochemical assays confirmed as being highly
aggregation prone, did not exhibit a FRET signal over extended
time (Supplementary Figure 1E), suggesting its inability to
aggregate when fused to CyPet/YPet. The large size of the
fluorescent probes immediately after the polyQ domain could
in fact inhibit the ability of the polyQ to self-associate and
promote aggregation (Holloschi et al., 2014). To test whether
we could overcome this structural hindrance and obtain a FRET
signal, we titrated increasing amounts of untagged 1P mutant
into the 1P-CyPet/YPet pair, always maintaining the same final
concentration of 3 µM (Figure 3C). Adding only one quarter
of untagged 1P mutant (+1/2x Q481P – turquoise line) to the
1P-CyPet/YPet mix resulted in a delayed FRET signal compared
to the Q48 control (gray line), commencing at approximately
12 hours. Mixing equimolar amounts of tagged and untagged
1P (+1x Q481P – celeste line) shifted the aggregation initiation
to an earlier time point, now matching the control. Further
increasing the concentration of untagged 1P mutant (+2x/+4x
Q481P – blue/dark blue lines) resulted in faster aggregation
kinetics (Figure 3C). These results suggest that once the polyQ
has initiated, uninhibited, its β-structure formation, tagged and
untagged moieties can also intercalate into the β-sheet formation,
in this case providing a readable FRET signal. It is therefore
important to acknowledge that placing any fluorescent probe
close to aggregation-prone domains might have profound effects
on its aggregation (Riguet et al., 2020).
To further consider the effects of the flanking domains only,
and compare simultaneously all mutants, we mixed the non-
variated Q48-CyPet/YPet with an equimolar amount of non-
tagged soluble HTTEx1 mutant (Figure 3D). As expected, the
1P mutant accelerated the rate of aggregation (dark blue line),
while deleting the anchoring N17 domain (1N17) delayed it
(green line). Surprisingly, the 1P1 mutant spike promoted a shift
of the lag phase towards an earlier aggregation onset (purple
line), before the non-variated Q48. The P+ mutant spike also
resulted in a shift (orange line), towards the right and after
the non-variated Q48 (gray line), indicating slower aggregation
kinetics. These two results are in opposition to the findings
of the previous experiment, but not necessarily contradicting:
an expanded proline might allow faster self-association in the
presence of other expanded prolines, but not as easily when this
region is short or missing. Lacking the P1 can bring already
formed β-strands into close contact and thus promote further
formation of polyQ β-sheets.
To understand whether the contribution of the flanking
regions to aggregation is intrinsic to their sequence or whether
it is dependent on the presence of an expanded polyQ stretch, we
decided to test the 1P1, P+ and non-variated HTTEx1 mutants
containing Q23 in the FRET assay (Figure 3E). Glutamine
stretches below the threshold of Q35 are not pathogenic and
are not known to aggregate in vivo. However, given enough
time and at high enough concentrations, shorter stretches
of glutamines have been reported to aggregate (Chen and
Wolynes, 2017). Our own data confirms this: at very high
concentrations (Supplementary Figure 1F), non-variated Q23
has a long lag phase of approximately two weeks (light gray
line), before beginning a very slow aggregation phase following
the expected sigmoidal kinetics. At the same concentration, the
presence of an expanded proline in the Q23P+ mutant (light
orange line), drastically reduces the lag phase by a third, and
removal of the protective P1 domain in the Q231P1 mutant
(pink line), accelerates aggregation six folds. When considering
short Q stretches, the proline domain emerges clearly as a
regulator of aggregation: removal of P1 might bring the polyQ
sufficiently into proximity to trigger a conformational change and
initiation of aggregation. Again, elongation of the prolines has
a similar outcome as proline-proline interactions also facilitate
the association and assembly of the polyQ (Figure 3D). To
further dissect the contribution of the flanking domains only,
we spiked the non-variated Q48-CyPet/YPet with the HTTEx1
mutants containing Q23 (Figure 3F). Expectedly, the addition
of the non-variated Q23 provided the greatest inhibition (light
gray line), slowing aggregation and expanding the lag phase. On
the opposing side, deletion of the 1P domain (light blue line),
enhanced aggregation almost as if the reaction was containing
exclusively constructs with Q48. Elongation or deletion of the
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FIGURE 3 | Deletion or expansion of PRD facilitates aggregation even for short polyQ variants. (A) Schematic of the FRET-based aggregation assay: upon addition
of PP, CyPet/YPet tagged HTTEx1 mutants initiate aggregation, generating a readable and increasing FRET signal. In some experiments, the CyPet/YPet-tagged
HTTEx1 moieties are mixed with non-tagged mutant HTTEx1, or ‘spiked.’ A fully aggregated reaction will be illustrated by a sigmoidal curve reaching a plateau over
time, while soluble moieties will appear as flat lines. (B) FRET analysis of HTTEx1 mutants individually tagged with CyPet/YPet. The FRET signal of the non-variated
Q48-CyPet/YPet serves as control (gray line). (C) FRET analysis of 1P mutants: due to the steric hindrance imposed by the fluorophores (as illustrated in the cartoon
schematic), readable FRET signals only appears when Q481P-CyPet/YPet pair is spiked with untagged 1P, with faster kinetics with increasing untagged Q481P
concentration. (D) FRET analysis of non-variated Q48-CyPet/YPet spiked with equimolar amounts of non-tagged HTTEx1 mutants with Q48-CyPet/YPet. Lag
phases are shifted closer to each other (compare to (B)). (E). FRET analysis of the aggregation of selected HTTEx1 mutants expressing the physiological Q23.
Aggregation of these Q23 mutants were also compared to non-variated Q48-CyPet/YPet control (gray line). (F) FRET analysis of non-variated Q48-CyPet/YPet
spiked with equimolar amount of HTTEx1 mutants with physiological Q23. Unless stated in the legends, final concentration for each reaction is 3 µM. All results are
representative of at least three independent repeats.
P1 (light orange and pink lines, respectively) resulted in a
diminished slope inclination, suggesting that the involvement of
this domain is somewhat beneficial, as aggregation is slowed,
but their role is more complex than a simple delaying function.
Interestingly, the deletion of the N17 did not slow aggregation
(green line), potentially suggesting that once the initial nucleus is
formed, the N17 is not required for further binding; an action
that might be promoted by the prolines instead (Figure 3E).
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Of note, in all FRET experiments curves are normalized to the
non-variated Q48; an increase in the efficiency of the FRET
signal over 100% can be explained by the positioning and spatial
arrangement of the fluorophores, imposed by the presence or
absence of HTTEx1 domains themselves.
Overall, our in vitro results revealed that expanding the P1
enhanced the aggregation propensities of HTTEx1. Removing the
P1 resulted instead in an ambivalent behavior, favoring both an
increase and a delay of aggregation, compared to the non-variated
HTTEx1 control. While both outcomes are so far contrary to
our initial hypothesis, we decided to investigate the role of the
flanking domains in vivo, in a cellular context, where the PRD
might show a clear beneficial involvement against aggregation
and toxicity, as promoted by evolution.
Expanded Prolines Maintain HTTEx1
Soluble in vivo
The in vitro results obtained so far highlighted that the
contribution to aggregation of the PRD, and especially of its P1
domain, is complex. We thus aimed to better understand the
impact of the flanking domains on aggregation and consequently
correlate these to toxicity in a living animal and during aging
by employing the C. elegans model organism. The nematode has
emerged as a powerful system to study the neurodegenerative
disorders and many strains expressing aggregation and disease-
related proteins have been generated (Li and Le, 2013; Kim
et al., 2016). To our knowledge however, no other C. elegans
strain exists that expresses the human HTTEx1 throughout
the nervous system.
We generated nematode strains expressing HTTEx1, and all
our described mutant forms, with either Q23 or Q48. To follow
aggregation, live and in vivo, we tagged the HTTEx1 constructs
with a nematode codon optimized mScarlet fluorophore. To
avoid the steric hindrance of the bulky fluorescent probe on
the aggregation kinetics (as seen for the CyPet/YPet constructs
in vitro; Figure 3C) we employed a strategy that would express
the HTTEx1 moiety twice under the control of a single operon
(Figure 4A; Gallrein et al., 2021). A non-tagged moiety of
HTTEx1 is constitutively expressed in the nervous system of
the nematode from early development onwards, under the
control of the pan-neuronal rgef-1 promoter. A second HTTEx1
moiety fused C-terminally to mScarlet, is expressed stochastically
and sub-stoichiometrically under the control of the hsp-3
internal ribosome entry site (IRES) (Figure 4B, Supplementary
Figure 2A). Over time tagged and non-tagged HTTEx1 proteins
are incorporated to form oligomeric and subsequently higher
aggregated entities. Importantly, thanks to the transparent
properties of the nematode, HTTEx1 can be followed non-
invasively and non-destructively in its path of aggregation
(Figure 4C, Supplementary Figures 2B–D). To distinguish
between the conformational species formed in vivo, we employed
fluorescence lifetime imaging (FLIM). FLIM has been adapted to
distinguish the formation of soluble, oligomeric and aggregated
moieties in vivo in C. elegans (Kaminski Schierle et al., 2011;
Gallrein et al., 2021). FLIM measures the fluorescence lifetime
(tau, τ), expressed in nanoseconds (ns), of a fluorescent
molecule. The lifetime τ is an absolute property intrinsic to the
fluorophore itself and varies only when its structural properties
or surrounding environment changes. Lifetimes are therefore
not steady state intensity measurements and are independent
of fluorophore concentrations (Becker, 2012). This feature is
particularly important as the expression levels of HTTEx1 are
not equal throughout the different strains analyzed and/or exhibit
a reduction in levels or suffer instability during aging. Fused
to our HTTEx1 mutants, the fluorescent lifetime of mScarlet
differs due to its altered conformational setting: when mScarlet
is in proximity or encased in the tightly packed environment of
an aggregate, the fluorophore undergoes molecular quenching
and its apparent τ value diminishes (Figure 4C; Chen et al.,
2017). Decrease, or variations, in τ values become a direct proxy
readout for HTTEx1 aggregation and the species that populate
this transition (Figure 4C).
We therefore set out to investigate and compare the
aggregation landscapes of HTTEx1 mutants in vivo in our HD
C. elegans models during aging by measuring the τ values
in the head neurons of young, day 4, and old, day 10,
nematodes (Figure 4D). Within the cellular environment of
a young nematode’s neurons, the average τ of the mScarlet
control strain, which expresses only the soluble fluorophore, is
3.3 ns. Compared to this control strain, the average τ of all
HTTEx1 strains was significantly lower already at day 4, with
the inexplicable exception of 1N17Q48 strain. Noticeably, the
τ values of 1P mutants were the lowest recorded for both the
Q231P and especially the Q481P expressing strains, which
dropped as low as 2.85 ns, demonstrating strong aggregation
in vivo (Figure 4E, Supplementary Table 2). These results are
in agreement with previous data (Dehay and Bertolotti, 2006;
Gruber et al., 2018) and highlight the protective role of the PRD,
which, once removed, exacerbates the aggregation propensity
of HTTEx1, even when a short non-pathogenic polyQ stretch
is present. P+, 1P1 and 1N17 HTTEx1 mutant strains all
exhibited significantly higher τ values compared to the 1P
mutants, almost all above 3 ns and up to 3.4 ns, indicating
that a larger part of the PRD is required to maintain HTTEx1
soluble. Interestingly, the non-variated HTTEx1 exhibited a τ
value significantly higher only compared to the Q481P mutant,
raising ambiguity regarding the presence and role of the P1
region in the aggregation propensities of HTTEx1, at early life
stages (Figure 4E, Supplementary Table 2). For each of the other
HTTEx1 mutants, the average τ values were similar despite the
presence of physiological Q23 or expanded Q48, confirming that
in young nematodes, the organism is still capable of suppressing
aggregation (Labbadia and Morimoto, 2015).
In old nematodes at day 10, we noticed immediately a
significant reduction of τ for all HTTEx1 mutants, including the
mScarlet control, but excluding the Q48P+ strain (Figure 4F).
The τ of Q48P+ remained elevated, with an average value
of 3.18 ns and 3.12 ns at day 4 and day 10 respectively,
indicating that the expanded proline region maintains soluble
HTTEx1 containing a pathologic stretch of Q48 during aging
(Supplementary Figure 3A; Supplementary Table 2). For all
mutants, including the control, an increase in aggregation and
consequently decrease in τ is expected as the result of natural
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FIGURE 4 | The expanded proline domain maintains HTTEx1 soluble in vivo. (A) Schematic of the DNA construct used to generate the HTTEx1 C. elegans strains.
A first moiety of HTTEx1 is transcribed under the control of a constitutively expressed neuronal promoter (rgef-1). A second HTTEx1 moiety fused to the mScarlet is
transcribed under the control the hsp-3IRES. (B) Representative images of the fluorescent nematode strains. Top panels show the mScarlet control strain, while
bottom panels show the Q481P mutant. Whole nematode images, showing the transmission and mScarlet channels, are magnified 100x, scale bar 100 µm; while
head (1) and tail (2) neurons, corresponding to the squared highlighted regions, are magnified 630x times, scale bar is 20 µm. (C) Graphical representation of the
aggregation and consequent lifetime readout of the different constructs by FLIM analysis. Aggregated fractions contain both tagged and untagged HTTEx1 and will
record a low fluorescence lifetime τ-value, while soluble moieties of tagged HTTEx1 will maintain a high fluorescence lifetime τ value. (D) TCPSC-FLIM pseudo-color
images of representative nematode head neurons depicting the average lifetimes for each HTTEx1 C. elegans strain, at either day 4 (left) or day 10 (right). Average
lifetime τ values ± SD (ns) are stated below each respective image. Dashed lines delimit the head region, magnified ≈1000 folds. High fluorescent lifetimes τ tend
towards a red color, while low t tend towards blue, as referenced by the color scale on the left representing 2.3 to 3.5 ns. Lifetime calculations and images were
generated with FLIMfit software (v. 5.1.1). (E,F) Truncated violin plots representing the average lifetimes recorded from the head neurons of nematode HTTEx1
strains, at day 4 (E) and day 10 (F) of life. Each circle represents an analyzed nematode. The median is shown by the single black thick line, while quartiles are
delimited by above/below dotted lines. Three independent cohorts of at least 10 individual nematodes each were imaged. For statistical significance, a one-way
ANOVA followed by Tukey post hoc test, assuming a confidence interval of 95%, was performed (∗ = p < 0.05; ∗∗ = p < 0.01; ∗∗∗∗ = p < 0.0001). For clarity, only
selected significance is shown, for a full table of significance refer to Supplementary Table 2.
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aging, changes in cellular environment, and collapse of the
proteostasis network (Ben-Zvi et al., 2009). Importantly, there
was a widening of τ values among the tested cohorts in almost all
mutants, indicating the presence of a more variated, and possibly
polymorphic, population of soluble, oligomeric and aggregated
species formed during aging (Figure 4F). This observation was
particularly true for both 1P1 mutants, containing either Q23
or Q48, in which deletion of the P1 region resulted in a much
broader and lower set of average τ values during aging, ranging
between a high of 3.27 ns and a low of 2.74 ns. Here, different
populations of oligomeric species were clearly visible, illustrated
by the repeating bulging areas of the violin plots. Nonetheless,
the beneficial effects of the P1 were highlighted by the higher
τ maintained in the strains expressing an expanded proline,
in both Q23 and Q48. During aging, Q23P+ and Q48P+
strains exhibited significantly higher τ values, with an average
above 3.10 ns and similar to the mScarlet control, and with
less species variation, suggesting an overall ability to maintain
HTTEx1 soluble. In contrast, the 1P mutants again recorded
the overall lowest τ, indicating that aggregation worsens further
over aging and especially when the protective PRD domain is
missing, illustrated by a reduction in average τ values from
above 3 ns to a low of 2.84 ns. Our FLIM results emphasize the
modulations imposed by the flanking regions, and specifically
the importance of the P1, and generally the PRD, in delaying
aggregation and maintaining the solubility of HTTEx1 in living
and aging C. elegans.
Expanded Prolines Promote Beneficial
Behavior in vivo Only for the Pathogenic
Q Stretch
The polyQ flanking regions of HTTEx1 have a role in
aggregation that has barely been studied or appreciated
in vivo (Shen et al., 2016). Our FLIM measurements
highlight the ability of these domains to directly influence
aggregation, positively and negatively, by either promoting the
solubility or advancing the oligomerization and aggregation
of HTTEx1. With its expanded polyQ domain, HTTEx1 is
a toxic protein either by loss of function or gain of toxic
function (Zheng and Diamond, 2012). The exact nature of
the toxic species is still highly debated, and several lines
of evidence demonstrate all structures, soluble, oligomer
or aggregated protein, as potential culprits of neuronal
cytotoxicity (Arrasate and Finkbeiner, 2012). With knowledge
from FLIM measurements of the nature of the mutants’
conformation (Figures 4E,F), we investigated HTTEx1’s
toxicity in C. elegans. We characterized our models and the
damage inflicted by each mutant on the physiology of the
nematode by performing a set of phenotypic assays (Figure 5
and Supplementary Tables 3, 4). For clarity, we focused on
the 1P and P+ strains, and their controls, but results and
analyses for all HTTEx1 mutant strains can be found in the
supplementary material (Supplementary Figures 3B–E and
Supplementary Tables 3, 4).
We first analyzed the impact of mutant HTTEx1 on the
lifespan of the nematode by performing a survival assay
(Figure 5A), an established method to assess the toxicity of
amyloidogenic proteins in models of neurodegenerative diseases.
It quickly emerged that both Q231P and Q481P strains (light
blue and dark blue lines respectably), which are devoid of the
protective PRD and exhibited high aggregation load in the FLIM
measurements (Figure 4F), were quickly dying. Surprisingly, the
Q23P+ (light yellow line) nematodes also exhibited a reduced
half-life and perished significantly faster than the mScarlet
control (red line). Conversely, the Q48P+ strain (orange line)
exhibited a survival rate close to that of mScarlet control and
to the non-variated Q23 strains (light gray line), indicating that
an expanded proline adjacent to an expanded polyQ is beneficial
in promoting survival. 1P1 and 1N17 strains also exhibited
long lifespans, again highlighting the importance of possessing a
PRD, either in its entirety or with minor modifications (Veldman
et al., 2015) (Supplementary Figure 3B). The lifespan is useful
to assess the general impact of HTTEx1 on the nematode.
To assess early adverse effects on the fitness of the organism,
we performed a fecundity assay (Figure 5B, Supplementary
Figure 3C). After counting the progeny of each HTTEx1 mutant
strain, it became apparent that the Q23P+ strain (light orange
column) was severely impaired in its reproduction capacities,
by more than half, compared to all other mutant strains, while
a less pronounced reduction in egg laying was also noticeable
for the Q231P nematodes (light blue column). Analysis of
several independently generated Q231P lines also reported a
decreased progeny count, suggesting that the impaired fecundity
is not due to damage provoked by integration into genes
specifically important for reproduction. Such drastic reduction
in offspring number for the Q23P+ strain pointed to a severe,
and unexpected, impairment imposed by the expanded proline
on the health of the organism from early stages. To characterize
the neurodegenerative component of our HD model strains, we
then assessed neuronal function by subjecting the nematodes to
a chemotactic assay (Figure 5C, Supplementary Figure 3D): fit
nematodes move away from a volatile repulsive substance, move
towards an attractant, while having no preference for a neutral
stimulus. Selected nematode strains responded as expected to
the repulsive, and potentially harmful substance, and to the
control. In response to the attractant, a mixture of behaviors
was observed: again, the Q23P+ nematodes were impaired
compared to controls, further demonstrating the extensive
detrimental potential of this HTTEx1 mutant on the fitness of
the nematode (Figure 5C). Interestingly, the 1N17 mutants
performed poorly overall, possibly due to their compromised
locomotion, a feature reported by other models lacking the
N17 domain (Gu et al., 2015). We cannot however explain the
complete inability of 1P1 strains to detect attractive odorants
(Supplementary Figure 3D). Finally, to assess the stability or
degeneration of muscle-neuron connectivity, we performed a
motility assay (Figure 5D). We counted the number of thrashes
performed in liquid for each HTTEx1 mutant strain at both
day 4 and day 10 of the nematodes’ life. The Q23P+ strain was
unable to perform more than 35 thrashes every 30 s, less than
half compared to the average of most other HTTEx1 mutant
strains, including the Q48P+ (Figure 5D). During aging, the
same significance pattern emerged, albeit all strains experiencing
Frontiers in Molecular Neuroscience | www.frontiersin.org 14 October 2021 | Volume 14 | Article 721749
fnmol-14-721749 October 11, 2021 Time: 16:28 # 15
Pigazzini et al. Expanded PRD Maintains HTT Soluble
FIGURE 5 | The expanded proline is beneficial in vivo in the presence of pathogenic, but not physiological polyQ tracts. (A) Lifespan assay, illustrated with a
Kaplan-Mayer plot, of selected C. elegans HTTEx1 mutant strains alongside the mScarlet control strain. Three independent repeats were performed of at least 120
nematodes each. On the right are shown the mean and standard error, and the maximum lifespan values for each strain. For significance a log-rank test was
performed (∗∗∗ p < 0.000001; ∗∗∗∗ = p < 0.0000001). Only selected values of significance are shown, for a full table of significance refer to Supplementary
Table 3. (B) Scatter dot plot with bar of the progeny assay performed for selected C. elegans HTTEx1 strains and mScarlet control. The average number of
offsprings recorded from three independent repeats, of 20 nematodes each, is shown as mean ± SD. Significance is calculated performing a one-way ANOVA
followed by Tukey’s post hoc test and assuming 95% confidence interval (∗∗∗∗ = p < 0.0001). (C) Grouped bar plot of chemotactic assay performed on selected
C. elegans HTTEx1 mutant strains alongside the mScarlet control strain. Shown is the mean ± SD of three independent repeats. The chemotaxis index is calculated
between the whole nematode plate cohort and the nematodes present on the test substance quadrant, either an attractant (1% benzaldehyde), a repellent (50%
benzaldehyde) or a control substance (EtOH). Significance was tested with a one-way ANOVA followed by Tukey’s post hoc test and assuming 95% confidence
interval (∗ = p < 0.05). (D) Scatter dot plot of the thrashing assay performed on selected C. elegans HTTEx1 strains and mScarlet control strain, on young day 4
nematodes and on old day 10 nematode. The average number of thrashes performed in M9 liquid medium every 30 s is shown as mean ± SD. Between 30-45
nematodes per strain were analyzed in three independent repeats. For significance, a one-way ANOVA followed by Tukey post hoc test assuming 95% confidence
interval was performed (∗∗∗ = p < 0.001; ∗∗∗∗ = p < 0.0001). For clarity, only selected significance results are shown for figures (B) and (D), for a full list of
significance refer to Supplementary Table 4.
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a general diminishing in the average number of thrashes. Again,
the motor impairment of the 1N17 mutants is reflected in their
decreased thrashing ability, which worsens significantly over time
(Supplementary Figure 3E).
Overall, the phenotypic characterization of the nematode
HTTEx1 strains revealed a complex picture of behaviors imposed
by the presence or absence of the flanking domains, or indeed
by the polyQ itself. The lifespan assay confirms the toxic effects
of aggregation load on survival, in accordance with the FLIM
data. Instead, the effect of aggregates, or even oligomeric and
monomeric species, is much more nuanced in other nematode
behaviors tested. Further assays are warranted to understand the
biological relevance and impact of HTTEx1 in the nervous system
of C. elegans to fully appreciate the subtle difference imposed by
all HTTEx1 flanking regions.
DISCUSSION
Huntington’s disease is caused by an expansion in the polyQ
stretch of HTTEx1. Although this genetic cause of the disease
is undisputed, the actual involvement of the protein’s polyQ
region in pathology is being scrutinized. In this study, we
investigated and dissected the contribution of the domains
flanking the polyQ stretch in HTTEx1 and elucidated the
specific contribution of the first pure repeat of prolines, the
P1, immediately adjacent to the C-terminal of the polyQ. We
hypothesized that the P1 has been expanding in mammals
to counteract the concomitant expansion of the polyQ, thus
allowing HTTEx1 to maintain, or even improve its function,
rather than promote pathology. Unlike previous studies that
employed only fragments or unnatural mutations of HTTEx1,
we analyzed the N17 and PRD, in the context of both
physiological and pathological polyQ expansions, and their
singular involvement in aggregation in vitro and in vivo. Our
in vitro experiments employed both fusion constructs and
untagged HTTEx1 recombinant proteins, to prevent altered
ultrastructural and biochemical properties imposed by the
fluorescent tags (Vieweg et al., 2016). Similarly, in our C. elegans
models we circumvented the potential issue imposed by steric
hinderance of the fluorophore and studied HTTEx1 aggregation
and toxicity in a relevant cellular and organismal context,
without excluding any contributions from PTMs, tissue crosstalk,
interaction partners and aging. Our results showcase some
contradictive behavior between in vivo vs in vitro experiments
(Supplementary Figure 4; Lashuel, 2021), but nonetheless
emphasize a clear involvement of flanking domains in defining
the aggregation landscape of polyQ proteins. Specifically, our
study in living animals confirmed the PRD as the protective entity
of HTTEx1 and the P1 as the evolutionary addition to expanding
polyQ with the purpose of maintaining HTTEx1 function whilst
avoiding pathology.
Similar to previous studies we found that the PRD exhibited
a protective function and, once removed, the remaining N17-
polyQ fragment exacerbated the aggregation propensity of
HTTEx1 (Bhattacharyya et al., 2006; Dehay and Bertolotti,
2006; Darnell et al., 2007). All biochemical assays confirmed
that Q481P aggregated with fast kinetics into large structures
that were fully SDS-insoluble (Figures 2B,F). Q481P mutants
had a detrimental effect also on the aggregation kinetics of
non-variated Q48, when mixed, facilitating a faster and earlier
aggregation (Figure 3D). An increase in surface availability
between the polyQ stretches of the non-variated Q48 and
of Q481P might occur once the hinderance imposed by
the PRD helix, or indeed the fluorophore, was removed
(Figures 3C,D). This shift in aggregation kinetics of non-
variated Q48 occurred even when the PRD was missing in
the context of Q23, further highlighting the protective role of
the PRD, independently of polyQ length (Figure 3E). Absence
of the PRD translates into a loss of the dynamic PPII helix
(Darnell et al., 2009): the remaining polyQ, regardless of its
Q number, is possibly facilitated into transitioning from a
helical structure into an aggregation-prone β-sheet (Kim et al.,
2009; Bugg et al., 2012). While our in vitro results are in
agreement with previous studies, we further confirmed the
behavior of the PRD in vivo in a living and aging organism.
FLIM measurements demonstrated that removing the PRD
resulted in the presence of aggregated species already in
young nematodes, which increased with aging for both polyQ
expansions (Figures 4E,F). When correlating aggregation load to
toxicity, lifespans of these 1P nematode strains were significantly
decreased compared to controls (Figure 5A). However, their
overall fitness, measured by chemotaxis, motility and fecundity
assays, did not appear impaired, except for the fertility of the
Q231P strain (Figure 5B). These results suggest that aggregates
themselves might not actively disrupt important processes, nor
are they toxic from their inception. Instead, over time aggregates
could remove from the cell the necessary resources required
for proper cell functioning, ultimately leading to the collapse
and death of the organism, through for example sequestration
of chaperones or space utilization (Kaganovich et al., 2008;
Olzscha et al., 2011; Arrasate and Finkbeiner, 2012). Previous
studies reported that large fibrillar aggregates intercalate with
membranous compartments, for example of the endoplasmic
reticulum, with noxious consequences on cell integrity (Kirstein
et al., 2015; Bäuerlein et al., 2017). Furthermore, cleavage
or disaggregation of large inclusion into smaller fibrils also
contributed to seeding effects and potential non cell autonomous
propagation of toxic species (Tipping et al., 2015; Tittelmeier
et al., 2020). While removal of the PRD is a trigger of
aggregation and aggregates have negative consequences on the
cell’s homeostasis, the monomeric 1P could also be involved
in promoting toxicity. The PRD itself was found to be the
site of important binding interactions, as proline residues
specifically engage partner proteins containing SH3 and WW
domains. Disruption of these interactions resulted in loss of
non-reception signaling, degradation capabilities and mRNA
processing, contributing to HD pathology (Liu et al., 1997;
Faber et al., 1998). In a previously established mouse model
of HD that lacked the PRD no dysfunctional phenotype or
developmental impairment compared to wild type was observed
and only a late life loss of memory was reported (Neveklovska
et al., 2012). Notably, full length HTT was used in this study,
and the presence of other HTT domains might compensate
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the loss of the PRD and its many interactions. Indeed the
precise role of the PRD appears complex and its subtle function
in mammals with higher cognitive capabilities is still hard to
fully appreciate.
Huntingtin is a conserved protein throughout species, with
orthologs emerging already in amoebas. The proline rich region,
and specifically P1, is a recent evolutionary adjunction present
exclusively in mammals: its increasing length correlating to the
apparent cognitive and brain expansion (Zuccato and Cattaneo,
2016). The presence of a C-terminal polyP stretch of only 5 amino
acids is already sufficient in delaying aggregation (Bhattacharyya
et al., 2006). Repeats of pure prolines are not placed randomly
within protein sequences and serve a definite function especially
when flanking Q stretches (Ramazzotti et al., 2012), and indeed
homo-repeats of any kind permit specialized biological tasks
(Jorda and Kajava, 2010). Expanding the P1 region, from 11P
to 22P, resulted in an increased aggregation potential in vitro
(Figures 2, 3), possibly due to the extended contact area newly
created by the large proline stretch, which are able to engage
in homotypic binding, as occurs in other proline rich proteins
(Vazquez-Portalatin et al., 2020). The same increased aggregation
potential was promoted by 22P when flanking a short Q23
stretch, suggesting that the homo-proline association proceeds
the polyQ association and is sufficient to enhance the polyQ-
mediated effects (Figures 3E,F). Q48P+ aggregates were however
SDS-soluble, in contrast to the 1P mutant, suggesting that the
presence of prolines might produce HTTEx1 aggregates that
are more fragile and frangible in nature (Shen et al., 2016).
PolyP-induced binding and fibril formation might represent a
less stable interaction than that produced by the polar zipper of
the polyQ, as the transition into a β-structure might be avoided
or delayed. In the packed environment of the cell, however,
the highly dynamic expanded P22 cannot self-associate as freely
as in vitro and might become a better target for interacting
partners. Furthermore, the helical nature of the polyP could
prevent the formation of an aggregate-inducing β-structure by
conformationally propagating itself into the polyQ, maintaining
the high energy barrier required to prevent polyQ transition into
a stable β-sheet (Hoop et al., 2016; Urbanek et al., 2020a,b).
Indeed, HTTEx1 with an expanded polyP stretch is maintained
soluble in vivo, regardless of polyQ size, as demonstrated by
the high fluorescence lifetime τ recorded for both Q23P+
and Q48P+ (Figure 4D). The high solubility of HTTEx1
translated into beneficial effects for the fitness and survival of
the nematode (Figure 5), but surprisingly, only for the Q48P+.
This result was in agreement with our hypothesis that expanding
prolines counteracted the effects of expanded glutamines.
Expanded prolines however were extremely deleterious in the
presence of short non-pathogenic polyQ stretches (Figure 5).
Counterintuitively, HTTEx1 containing a short polyQ flanked by
a long polyP conferred higher toxicity to an animal than HTTEx1
with an expansion of both polyQ and polyP. These results point to
the flanking domains as joint regulators of toxicity in vivo rather
than the mutant polyQ alone.
In what form and how HTTEx1 causes pathology is still
unknown, as both a detailed structure (Guo et al., 2018) and
a thorough characterization of its function are incomplete.
Theoretical and experimental evidence based on biological
data and in silico simulations have produced contradicting
and contrasting models. The linear lattice model (Figure 6A)
suggested that monomeric HTTEx1, either possessing a
physiologic or a pathogenic polyQ stretch, maintains the same
overall structure in vitro oscillating between a random coil or
α-helices (Bennett et al., 2002; Li et al., 2007; Bravo-Arredondo
et al., 2018). Toxicity arises as expanded Qs allow for a greater
number of binding sites due to a larger polyQ surface, which
in turn stimulates ligand interactions (Warner et al., 2017;
Newcombe et al., 2018). These avidity effects cause higher
affinity interactions and result in altered binding with partner
proteins or other polyQ domains, leading to aggregation and
neurotoxicity. However, heterotypic interactions, some of which
might push mutant HTTEx1 into a gain of toxic function, could
also present with protective effects, depending on the nature of
the ligand (Posey et al., 2018; Ceccon et al., 2020). In contrast
to this hypothesis, the ‘emergent conformation’ model, also
known as ‘structural toxic threshold’ (Figure 6B), proposes
that HTTEx1 assumes a length-dependent toxic conformation
by transitioning from monomers into dimers, trimers and
tetramers, into larger still diffusible small oligomers, and down
the amyloid formation pathway. It is still debated, which of these
conformational states represent the toxic species, but HTTEx1
needs to adopt a β-hairpin structure to promote cytotoxicity
(Sahoo et al., 2016; Wetzel, 2020). Breakage of this structure
by placing a mutation within the polyQ, or the N17, abrogated
the formation of amyloids in vitro (Thakur and Wetzel, 2002;
Atwal et al., 2007). HTTEx1 mutants that instead transitioned
quickly into β-structures promoted the formation of neurotoxic
oligomeric species, even with non-pathological Q stretches
(Truant et al., 2008; Drombosky et al., 2018). Results from our
investigation suggest that both models have merit and taken
together can fully explain HTTEx1 toxicity, especially in the
presence of an expanded P1 (Figure 6C). In accordance with the
lattice model, for which monomeric species would be responsible
for toxicity (Nagai et al., 2007), expanded prolines would allow
for larger surface binding interaction between HTTEx1 moieties
and both aggregation-enhancing and aggregation-delaying
ligands. First, our in vitro data confirmed the ability of the
dynamic proline stretch to form soluble fibrillar structures,
which translates into an overall high binding capacity. Our
FLIM data further suggested that the conformational species
present in the nematode are oligomeric, although the exact
size is unknown, as single molecule characterization is still
outside of the measurement’s sensitivity. These oligomeric
species might remain inert by binding to aggregation-delaying
interactors. Alternatively, due to the structural rearrangements
imposed by the flanking domains, and especially by the expanded
polyP adopting a PPII helix (Blanch et al., 2000), HTTEx1
could transition into a novel fold, of yet undefined structure.
The influence newly imposed by the expanded polyP onto
the polyQ differ in relation to the polyQ length itself. An
altered, now toxic, conformational state is imposed by expanded
prolines onto short Qs and would explain how this Q23P+
construct causes deleterious effects in the nematode’s fitness
and survival. Conversely, the same polyP expansion would
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FIGURE 6 | HTTEx1 P+ behaves both according to the linear lattice and the toxic conformant models. (A) The linear lattice model of HTTEx1 postulates that mutant
HTTEx1 itself is not intrinsically toxic. In the presence of Q48, but not Q23, the loss of important interactions partners or the addition of novel ones, renders the
monomeric HTTEx1 toxic via a gain of toxic function. (B) Conversely, the toxic conformant model postulates that mutant HTTEx1Q48 is toxic as the expanded polyQ
is capable of folding into a new β-structure that favors assembly into oligomeric species which are intrinsically toxic. (C) In the presence of an expanded proline, both
models might be correct: Q23P+ is toxic in vivo as it might both increase the surface availability for ligands, and/or assume a different conformation, arising from a
structural rearrangement imposed by the long polyP onto the short polyQ. For Q48-P+, the transition into toxic oligomers might be prevented by the long polyP
hindering the structural rearrangement of the expanded polyQ, thus diminishing toxicity. Overall however, the interaction network of HTTEx1-P+ might also favor an
increased amount of ligand binding, some of which might result in either beneficial or deleterious effects.
structurally propagate itself onto the expanded polyQ with
a different outcome. The resulting structure proved to be a
less toxic conformation, evident by the beneficial effects on
fitness and survival in the Q48+ nematode strain. Our results
in this scenario now align with the emergent conformation
model (Miller et al., 2011), which supports the rearrangement
of HTTEx1 into β-hairpin structures of oligomeric nature as
being the toxic culprits. It therefore emerges how the sequence
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context is much more important for modulating toxicity
than the polyQ alone (Lakhani et al., 2010). What structure
does the expanded P1 impose on the polyQ, what novel
partners might it recruit autonomously or in cooperation with
varying polyQ, and what is its role within the whole PRD,
are all questions that need to be addressed. Investigation
of the flanking regions of other polyQ disease proteins, for
example the ataxins, and their effects on the structure/toxicity
relationship, will further aid in understanding the importance
of the protein context and help uncover how variability in
neuronal vulnerability or pathological processes reside in the
interplay between the polyQ and its flanking domains. For
HD the role of the flanking domains in functionality and
toxicity in vivo is slowly being unraveled. Focusing on the
evolutionary newer PRD could also answer why the polyQ is
expanding in humans and how natural selection pressure is
working to prevent this functional mutation from causing a
devastating disease.
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